Intco Medical Technology Co., Ltd. Class A

Intco Medical Technology Co., Ltd. Class A

SSZSE:300677
49.42
CNY
+2.47
(+5.26%)
0.62EPS
103.11P/E
33.37BMarket Cap
Apr 28Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.27
1.68
2.88
3
3.89
3.6
3.96
24.11
24.76
9.99
10.48
14.69
15.52
21.73
Basic EPS, GAAP
0.03
0.06
0.19
0.22
0.32
0.34
0.34
12.21
11.33
0.95
0.58
2.26
1.58
0.49
Free Cash Flow per Basic Share
0.02
0.05
-0.2
-0.34
0.08
-0.23
-0.39
9.93
4.94
-0.98
-1.42
-1.1
-1.08
- -
Dividend per Share
0.03
0.02
0.03
0.04
0.03
0.05
0.1
0.28
1.64
0.69
0.28
0.52
0.66
0.94
Book Value per Share
0.46
0.53
1.05
1.36
2.05
2.4
2.76
14.74
24.05
23.97
24.43
26.93
27.86
27.96
Tangible Book Value per Share
0.41
0.47
1
1.28
1.99
2.23
2.39
14.19
23.09
23.08
23.57
25.75
26.75
26.84
Basic Weighted Avg Shares
315
525
347
394
450
526
526
574
656
662
660
648
640
604
Sales/Revenue/Turnover
713
885
998
1,183
1,750
1,893
2,083
13,837
16,240
6,614
6,919
9,523
9,926
13,120
Operating Margin (%)
3.93
5.72
8.47
8.8
11.64
10.31
10.77
62.47
53.4
-0.46
-1.46
10.91
9.81
19.87
Depreciation Expense
23
29
34
45
65
80
92
140
369
630
724
862
968
- -
Net Income, GAAP
11
32
64
86
145
179
178
7,007
7,430
629
383
1,465
1,011
298
Effective Tax Rate (%)
0.39
14.95
13.35
12.13
10.91
13.2
12.3
16.08
13.7
9.24
12.36
7.29
14.84
44.7
Profit Margin (%)
1.5
3.6
6.43
7.27
8.29
9.48
8.56
50.64
45.75
9.51
5.54
15.39
10.18
2.27
Working Capital
-187
-137
-10
-100
328
368
677
6,282
8,679
7,080
6,985
7,272
-2,879
-8,016
LT Debt
- -
17
- -
37
33
44
535
230
205
53
77
167
409
223
Total Equity
148
168
415
535
1,088
1,273
1,502
9,443
16,123
16,049
16,295
17,682
18,572
18,702
Return on Invested Capital (%)
- -
8.17
13.27
12.11
13.5
10.35
7.75
113.52
57.1
3.77
1.87
5.72
3.12
1.11
Return on Capital (%)
- -
10.28
14.43
12.71
14.08
11.19
8.81
114.83
56.71
3.79
2.38
6.34
3.85
1.16
Return on Common Equity (%)
- -
20.26
22.01
18.1
17.88
15.19
12.97
129.51
58.93
3.97
2.41
8.77
5.67
1.64

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
17,320
17,028
17,537
LT Borrowings
323
451
223
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
655
655
655
Market Capitalization
38,445
25,647
33,366

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
16,430
19,103
12,171
Cash, Cash Equivalents & STI
12,864
15,130
8,050
Accounts Receivable, Net
1,322
1,384
1,632
Inventories
1,694
2,053
1,997
Total Current Liabilities
19,481
19,466
20,187
Payables & Accruals
- -
- -
- -
ST Debt
17,320
17,028
17,537
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
78.12%
17.07%
5.03%
Free Cash Flow
-340.46%
-29.25%
-2.91%
Net Income, GAAP
408.22%
25.4%
-31.03%
Sales/Revenue/Turnover
65.36%
0.92%
4.23%
Total Cash Common Dividend
95.97%
110.09%
24.8%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,203
2,309
2,586
2,425
9,523
2025
2,494
2,420
- -
2,501
9,926
2026
2,887
4,022
3,710
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.36
0.54
0.16
1.21
2.26
2025
0.55
0.57
- -
0.14
1.58
2026
0.02
1.29
-0.98
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.18
0.09
0.16
0.52
2025
0.1
0.24
- -
0.14
0.66
2026
0.27
0.27
0.27
- -
- -

Company Description

CEO
Qiong Chen
Full Time Employees
12,941
Sector
Health technology
Industry
Medical specialties
Address
No.18, Qingtian Road Zibo SD China 255414
IPO Date
Jul 21, 2017
Business
Intco Medical Technology Co., Ltd., founded in 1995 and headquartered in Yantai, China, operates as a high-tech manufacturer specializing in the research, development, production, and sales of medical consumables, rehabilitation equipment, and physical therapy products. Its core product portfolio includes latex-free disposable gloves, nitrile gloves, PVC gloves, ECG electrodes, ESU accessories, face masks, face shields, medical pillows, mobility scooters, manual and electric wheelchairs, transfer machines, walking aids, nursing beds, and physiotherapy care products. Intco Medical serves medical institutions, nursing homes, households, and industrial sectors, with its products exported to over 150 countries across America, Europe, Asia, Africa, and Oceania. The company underwent significant growth and innovation in 2024 and 2025, reporting a 37.65% revenue increase to 9.523 billion yuan and a 282.63% rise in net profit, reflecting enhanced operational efficiency and strategic expansion. In 2025, Intco Medical launched 37 new products focusing on medical and healthcare advancements. It also expanded its rehabilitation equipment segment with the introduction of the E-LITE electric wheelchair and CAREFLEX nursing bed, integrating smart technology and ergonomic design. The company has furthered its commitment to sustainability by obtaining Life Cycle Assessment and carbon footprint certifications for its disposable glove products and earning high ESG ratings such as WIND Rating A and MSCI ESG BBB, positioning it as an industry leader in green manufacturing. Intco Medical maintains strong partnerships, including collaboration with JD Health for data-driven solutions targeting home healthcare and personal wellness markets. It continues to scale manufacturing capacity globally, supported by advanced automation and intelligent supply chain management, to meet growing international demand. The company’s strategic focus is on integrating medical consumables with rehabilitation and physiotherapy products to deliver comprehensive healthcare solutions. Intco Medical is publicly traded on the Shenzhen Stock Exchange under ticker 300677.SZ and benefits from a robust financial foundation, ongoing innovation, and a broad geographic footprint.